Aggressive Pituitary Tumors

ONCOLOGY

Volumn 12, Issue 9, 1998, Pages 1307-1315

  Blevins Jr , Lewis S ^a   Verity, Denise K ^a   Allen, George ^b  

^a VANDERBILT UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOMA; CANCER INVASION; CLASSIFICATION; HUMAN; HYPOPHYSIS TUMOR; PATHOLOGY; REVIEW;

ADENOMA; HUMANS; NEOPLASM INVASIVENESS; PITUITARY NEOPLASMS;

EID: 0032153464     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Burrow GN, Wortzman G, Rewcastle NB, et al: Microadenomas of the pituitary and abnormal sellar tomograms in an unselected autopsy series N Engl J Med 304:156-158, 1981.
2. Annegers JF, Coulam CB, Abboud CF, et al: Pituitary adenoma in Olmstead County. Minnesota, 1935-1977: A report of an increasing incidence of diagnosis in women of childbearing age. Mayo Clin Proc 53:641-643, 1978.
3. Blevins LS, Christy JH, Khajavi M, et al. Outcomes of therapy for Cushing's disease due to adrenocorticotropin secreting pituitary macroadenomas. J Clin Endocrinol Metab 83:63-67, 1998.
4. Fahlbusch R, Honneger J, Buchfelder M: Surgical management of acromegaly. Endocrinol Metab Clin North Am 21:669-692, 1992.
5. Mindermann T, Wilson CB: Thyrotropin-producing pituitary adenomas J Neurosurg 79:521-527, 1993.
6. Selman WR, Laws ER, Scheithauer BW, et al: The occurrence of dural invasion pituitary adenomas. J Neurosurg 64:402-407, 1986.
7. Sautner D, Saeger W: Invasiveness of pituitary adenomas. Pathol Res Pract 187:632-636, 1991.
8. Scheithauer BW, Kovacs KT, Laws ER, et al: Pathology of invasive pituitary tumors with special reference to functional classification. J Neurosurg 65:733-744, 1986.
9. Pegolo G, Buckwalter JG, Weiss MH, et al: Pituitary adenomas: Correlation of the cytologic appearance with biologic behavior. Acta Cytol 39:887-892, 1995.
10. Landolt AM, Shibata T, Kleihues P: Growth rate of human pituitary adenomas J Neurosurg 67:803-806, 1987.
11. Shivuya M, Saito F, Miwa T, et al: Histochemical study of pituitary adenomas with Ki-67 and anti-DNA polymerase a monoclonal antibodies, bromodeoxyuridine labeling, and nucleolar organizer region counts. Acta Neuropathol 84:178-183, 1992.
12. Hsu DW, Hakim F, Biller BMK, et al: Significance of proliferating cell nuclear antigen index in predicting pituitary adenoma recurrence. J Neurosurg 78:753-761, 1993.
13. Gandour-Edwards R, Kapadia SB, Janecka IP, et al: Biologic markers of invasive pituitary adenomas involving the sphenoid sinus. Mod Pathol 8:160-164, 1995.
14. Thapar K, Kovacs K, Scheithauer BW, et al. Proliterative activity and invasiveness among pituitary adenomas and carcinomas: An analysis using the MIB-1 antibody Neurosurgery 38:99-107, 1996.
15. Knosp E, Kitz K, Pereczky A: Proliferation activity in pituitary adenomas: Measurement by monoclonal antibody Ki-67. Neurosurgery 25:927-930, 1989.
16. Takino H, Herman V, Weiss M, et al: Punne-binding factor (nm23) gene expression in pituitary tumors Marker of adenoma invasiveness. J Clin Endocrinol Metab 80:1733-1738, 1995
17. Thapar K, Scheithauer BW, Kovacs K, et al. p53 Expression in pituitary adenomas and carcinomas: Correlation with invasiveness and tumor growth fractions Neurosurgery 38:765-771, 1996.
18. LeRiche VK, Asa SL, Ezzat S: Epidermal growth factor and its receptor (EGF-R) in human pituitary adenomas: EGF-R correlates with tumor aggressiveness J Clin Endocrinol Metab 81:656-662, 1996.
19. Alvaro V, Touraine P, Vozari RR, et al: Protein kinase C activity and expression in normal and adenomatous human pituitaries. Int J Cancer 50:724-730, 1992.
20. Saeger W, Lübke D: Pituitary carcinomas. Endocrinol Pathol 7:21-35, 1996.
21. Mountcastle RB, Roof BS, Mayfield RK, et al. Case report. Pituitary adenocarcinoma in an acromegalic patient: Response to bromocriptine in pituitary testing: A review of the literature on 36 cases of pituitary carcinoma. Am J Med Sci 298:109-118, 1989.
22. Pernicone PJ, Scheithauer BW, Sebo TJ, et al: Pituitary carcinoma: A clinical pathologic study of 15 cases. Cancer 79:804-812, 1997.
23. Bates AS, Buckley N, Boggild MD, et al: Clinical and genetic changes in a case of a Cushing's carcinoma. Clin Endocrinol 42:663-670, 1995.
24. Bates AS, Farrell WE, Bicknell EJ, et al: Allelic deletion in pituitary adenomas reflects aggressive biological activity and has potential value as a prognostic marker. J Clin Endocrinol Metab 82:818-824, 1997.
25. Horvath V, Kovacs K, Killinger DW, et al: Silent corticotrophic adenomas of the human pituitary gland. Am J Pathol 98:617-638, 1980.
26. Braithwaite SS, Clasen RA, D'Angelo CM: Silent corticotroph adenoma: Case report and literature review. Endocrinol Pract 3:297-301, 1997.
27. Raffin-Sanson M-L, Massias J-F, Dumont C, et al: High plasma proopiomelanocortin in aggressive adrenocorticotropin-secreting tumors J Clin Endocrinol Metab 81:4272-4277, 1996.
28. Grua JR, Nelson DH: ACTH-producing pituitary tumors. Endocrinol Metab Clin North Am 20:319-362, 1991.
29. Jenkins PJ, Trainer PJ, Plowman PN, et al: The long-term outcome after adrenalectomy and prophylactic pituitary radiotherapy in adrenocorticotropin-dependent Cushing's syndrome. J Clin Endocrinol Metab 79:165-171, 1994.
30. Kemink L, Pieters G, Hermus A, et al: Patient's age is a simple predictive factor for the development of Nelson's syndrome after total adrenalectomy for Cushing's disease. J Clin Endocrinol Metab 79:887-889, 1994.
31. Molitch ME, Elton RL, Blackwell RE, et al: Bromocriptine as primary therapy for prolactin-secreting macroadenomas: Results of a prospective multicenter study. J Clin Endocrinol Metab 60:698-705, 1985.
32. Molitch ME, Thorner MO, Wilson C: Management of prolactinomas. J Clin Endocrinol Metab 82:996-1000, 1997.
33. Pellegrini I, Rasolonjanahary R, Gunz G, et al: Resistance to bromocriptine in prolactinomas. J Clin Endocrinol Metab 69:500-509, 1989.
34. Kovacs K, Stefaneanu L, Horvath E, et al: Prolactin-producing pituitary tumor: Resistance to dopamine agonist therapy J Neurosurg 82:886-890, 1995.
35. Loh K-C, Shlossberg AH, Rittmaster RS, et al: Giant prolactinomas: A retrospective review. The Endocrinologist 6:257-263, 1996.
36. Davis JRE, Sheppard MC, Heath DA: Giant invasive prolactinoma: A case report and review of nine further cases. QJM 74:227-238, 1990.
37. Murphy FY, Vesely DL, Jordan RM, et al. Giant invasive prolactinomas. Am J Med 83:995-1002, 1987.
38. Siegel RD, Lee SL: Pneumocephalus and cerebrospinal fluid rhinorrhea after bromocriptine therapy of an invasive prolactinoma: A case report and review of the literature. The Endocrinologist 6:148-152, 1996.
39. Cohen DL, Diengdoh JV, Thomas GT, et al: An intracranial metastasis from a PRL-secreting pituitary tumor. Clin Endocrinol 18:259-264, 1983.
40. Moltich ME. Clinical manifestations of acromegaly. Endocrinol Metab Clin North Am 21:597-614, 1992.
41. Nabarro JDN: Acromegaly Clin Endocrinol 26:481-512, 1987
42. Jaffe CA, Barkan AL: Treatment of acromegaly with dopamine agonists. Endocrinol Metab Clin North Am 21:713-735, 1992.
43. Ezzat S, Snyder PJ, Young WF, et al: Octreotide treatment of acromegaly. Ann Intern Med 117:711-718, 1992.
44. Eastman RC. Gordon P, Glatstein E, et al. Radiation therapy of acromegaly. Endocrinol Metab Clin North Am 21:693-712, 1992.
45. Kovacs K: Pathology of growth hormone excess. Pathol Res Pract 183:565-568, 1988.
46. Tourniaire J, Trouillas J, Chalendar D, et al: Somatotrophic adenoma manifested by galactorrhea without acromegaly. J Clin Endocrinol Metab 61:451-453, 1985.
47. Klibanski A, Xervas NT, Kovacs K, et al: Clinically silent hypersecretion of growth hormone in patients with pituitary tumors. J Neurosurg 66:806-811, 1987.
48. Kovacs K, Lloyd R, Horvath E, et al. Silent somatotroph adenomas of the human pituitary. Am J Pathol 134:345-353, 1989.
49. Greenman Y, Woolf P, Coniglio J, et al: Remission of acromegaly caused by pituitary carcinoma after sugical excision of growth hormone-secreting metastasis detected by 111-indium pentereotide scan. J Clin Endocrinol Metab 81:1628-1633, 1996.
50. Dayan C, Guilding T, Hearing S, et al: Biochemical cure of recurrent acromegaly by resection of cervical spinal canal metastasis. Clin Endocrinol 44:597-602, 1996.
51. Horvath E, Kovacs, K, Sionger W, et al: Acidophil stem cell adenoma of the human pituitary: Clinicopathologic analysis of 15 cases. Cancer 47:761-771, 1981.
52. Page MD, Bridges LR, Barth JH, et al. Development of acromegaly during treatment of hyperprolactinemia with bromocriptine: An unusual acidophil stem cell adenoma. J Clin Endocrinol Metab 81:4484-4487, 1996.
53. Horvath E, Kovacs K, Singer W, et al: Acidophil stem cell adenoma of the human pituitary. Arch Pathol Lab Med 101:594-599, 1977.
54. Smallridge RC, Smith CE: Hyperthyroidism due to thyrotropin-secreting pituitary tumors. Arch Intern Med 143:503-507, 1983.
55. Gesundheit N, Petrick PA, Nissim M, et al: Thyrotropin-secreting pituitary adenomas: Clinical and biochemical heterogeneity. Ann Intern Med 111:827-835, 1989.
56. Beckers A, Abs R, Mahler C, et al: Thyrotropin-secreting pituitary adenomas: A report of seven cases. J Clin Endocrinol Metab 72:477-483, 1991.
57. Wynne AG, Ghaerib H, Scheithauer BW, et al: Hyperthyroidism due to inappropriate secretion of thyrotropin in ten patients. Am J Med 92:15-24, 1992.
58. Losa M, Giovanelli M, Persani L, et al: Criteria of cure and follow-up of central hyperthyroidism due to thyrotropin-secreting pituitary adenomas. J Clin Endocrinol Metab 81:3084-3090, 1996.
59. Chanson P, Weintraub BD, Harris AG: Octreotide therapy for thyroid-stimulating hormone-secreting pituitary adenomas. Ann Intern Med 119:236-240, 1993.
60. Mixson AJ, Friedman TC, Katz DA, et al: Thyrotropin-secreting pituitary carcinoma. J Clin Endocrinol Metab 76:529-533, 1993.
61. Young WF, Scheithauer BW, Kovacs KT, et al. Gonadotroph adenoma of the pituitary gland: A clinicopathologic analysis of 100 cases. Mayo Clin Proc 71:649-656, 1996.
62. Deauchesne P, Trouillas J, Varral F, et al: Gonadotropic pituitary carcinoma: Case report. Neurosurgery 37:810-815, 1995.